1. Home
  2. TANH vs VIVS Comparison

TANH vs VIVS Comparison

Compare TANH & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$0.37

Market Cap

4.8M

Sector

N/A

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.42

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
VIVS
Founded
2001
2007
Country
China
United States
Employees
N/A
9
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
VIVS
Price
$0.37
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
215.6K
44.5K
Earning Date
05-15-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
$0.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$1.25
52 Week High
$2.59
$5.30

Technical Indicators

Market Signals
Indicator
TANH
VIVS
Relative Strength Index (RSI) 40.88 42.74
Support Level $0.31 $1.43
Resistance Level $0.45 $2.21
Average True Range (ATR) 0.04 0.14
MACD 0.02 0.01
Stochastic Oscillator 49.06 16.66

Price Performance

Historical Comparison
TANH
VIVS

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: